Advertisement Biosign Technologies CEO resigns - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Biosign Technologies CEO resigns

Biosign Technologies has announced the resignation of its chairman and CEO, Richard Potts. In the interim Dr Leca will assume these roles.

Mr Potts said: “While pleased with much of the progress that has been made by Biosign, it is with deep regret but with great hope for the future of Biosign that I provide my resignation to the board of directors.

“I intend to assist Dr Leca in every possible manner in moving Biosign toward its important goal of becoming the world’s health monitor.”